Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01517243
Title Phase II Study of Alternating Sunitinib and Temsirolimus
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
University of Vermont, Vermont Cancer Center Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field